Michael Xue
Managing Director @ Morningside
Michael Xue is a seed investor at Morningside focused on Biotechnology. Michael Xue is the Managing Director of Morningside Venture Capital.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Michael Xue invests in
Stages Michael Xue invests in
Countries Michael Xue invests in
Investment Focus
Stage
- Seed 1 (50%)
- Series A 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Epigenic Therapeutics
|
Epigenic Therapeutics is a biotech firm that offers gene editing therapy. | $32M / Series A / Aug 29, 2023 | |
|
Epigenic Therapeutics
|
Epigenic Therapeutics is a biotech firm that offers gene editing therapy. | $20M / Seed / Aug 06, 2022 |
Co-Investors
About Morningside
Morningside makes venture capital investments in companies with novel science and technology. We are characterized by a long-term outlook in company-building and an unwavering commitment to acting ethically.Based in the greater Boston area, our team of entrepreneurial investment professionals has deep experience in life sciences, digital health,AI, materials and technology.Founded in 1986 as a family office for the Chan family, charitable commitments to education, research and healthcare include the Harvard T.H. Chan School of Public Health, the UMass Chan Medical School, and the MIT Morningside Academy for Design.
Morningside Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anthony Aiudi
Investment Professional
|
|||
Mick Sawka
Investment Manager
|
|||
Gerald Chan
Co-Founder, Investment Director & Board Member
|
|||
Justin Burns
Investment Professional
|
|||
|
Michael Xue
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Michael Xue invest in?
Michael Xue invests primarily in Biotechnology startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Michael Xue last invest?
The most recent investment recorded for Michael Xue closed in Aug 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
